Mesoblast (MEOBF) Net Margin Growth (3y) (2017 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) Net Margin Growth (3y) (2017 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -78,467.00 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 4.47 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 29,163.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 143,941.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.46 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 118,642.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 795.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1,380.00 |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -81,515.00 |
| Dec 31, 2022 | -31,454.00 |
| Sep 30, 2022 | -109,119.00 |
| Jun 30, 2022 | 30,983.00 |
| Mar 31, 2022 | 93,993.00 |
| Dec 31, 2021 | 58,198.00 |
| Sep 30, 2021 | -46,253.00 |
| Jun 30, 2021 | 9,944.00 |
| Mar 31, 2021 | 59,083.00 |
| Dec 31, 2020 | -124,874.00 |
| Sep 30, 2020 | -78,894.00 |
| Mar 31, 2020 | 162,836.00 |
| Dec 31, 2019 | 281,276.00 |
| Sep 30, 2019 | 655,214.00 |
| Jun 30, 2019 | -155,638.00 |
| Mar 31, 2019 | -138,807.00 |
| Dec 31, 2018 | -75,954.00 |
| Sep 30, 2018 | 8,746.00 |
| Jun 30, 2018 | -49,330.00 |
| Mar 31, 2018 | -145,109.00 |